Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  K. Sawanyawisuth,et al.  Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines. , 2014, International journal of oncology.

[3]  S. Walrand,et al.  The Low Hepatic Toxicity per Gray of 90Y Glass Microspheres Is Linked to Their Transport in the Arterial Tree Favoring a Nonuniform Trapping as Observed in Posttherapy PET Imaging , 2014, The Journal of Nuclear Medicine.

[4]  Tushar C. Barot,et al.  Yttrium-90 Microsphere-selective Internal Radiation Therapy With Chemotherapy (Chemo-SIRT) for Colorectal Cancer Liver Metastases: An In Vivo Double-Arm–Controlled Phase II Trial , 2013, American journal of clinical oncology.

[5]  P. Bernhardt,et al.  Radiation exposure during liver surgery after treatment with 90Y microspheres, evaluated with computer simulations and dosimeter measurements , 2012, Journal of radiological protection : official journal of the Society for Radiological Protection.

[6]  Zhao Xiaodan,et al.  Effect of 103Pd radioactive stent on caspase-9, cholangiocarcinoma cell growth and its radiosensitivity. , 2011, Surgical oncology.

[7]  Masatoshi Kudo,et al.  Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review , 2011, International journal of hepatology.

[8]  P. Kim,et al.  Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. , 2011, AJR. American journal of roentgenology.

[9]  Zhao-You Tang,et al.  Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients , 2010, BMC Cancer.

[10]  J. Siegel,et al.  Hepatic Structural Dosimetry in 90Y Microsphere Treatment: A Monte Carlo Modeling Approach Based on Lobular Microanatomy , 2010, Journal of Nuclear Medicine.

[11]  M. Aljiffry,et al.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. , 2009, World journal of gastroenterology.

[12]  A. Salmi,et al.  Efficacy of Radiofrequency Ablation of Hepatocellular Carcinoma Associated with Chronic Liver Disease without Cirrhosis , 2008, International journal of medical sciences.

[13]  F. Orsi,et al.  Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  C. Nutting,et al.  Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients , 2008, American journal of clinical oncology.

[15]  Mariana Guerrero,et al.  Radiobiological Modelling in Radiation Oncology , 2008 .

[16]  B. Erickson,et al.  Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation. , 2008, International journal of radiation oncology, biology, physics.

[17]  Xiao-peng Wu,et al.  Difference in biological characteristics and sensitivity to chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro. , 2008, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[18]  M. Reiser,et al.  Liver Radioembolization with 90Y Microspheres , 2008 .

[19]  W. Dezarn,et al.  90 Y Microspheres: Concepts and Principles , 2008 .

[20]  K. Tatsch,et al.  Nuclear Medicine Procedures for Treatment Evaluation , 2008 .

[21]  B. Warkentin,et al.  Radiobiological Modelling in Radiation Oncology , 2007 .

[22]  A. Benson,et al.  Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. , 2007, International journal of radiation oncology, biology, physics.

[23]  S. Gulec,et al.  Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio , 2007, Journal of Translational Medicine.

[24]  R. Wahl,et al.  Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement: a Monte Carlo-based dosimetric analysis. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  I. David P. Doane Ii. Lori E. Seward,et al.  Applied statistics in business and economics , 2006 .

[26]  C. Nutting,et al.  Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. , 2004, International journal of radiation oncology, biology, physics.

[27]  M. Soulen,et al.  Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. , 2004, Gastroenterology.

[28]  Charles R. Thomas,et al.  External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy. , 2004, Gastroenterology.

[29]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[30]  M. Burton,et al.  Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. , 2001, Physics in medicine and biology.

[31]  M. Burton,et al.  Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. , 2000, Physics in medicine and biology.

[32]  S. Zavgorodni.  A model for dose estimation in therapy of liver with intraarterial microspheres. , 1996, Physics in medicine and biology.

[33]  S. Okada.  [Chemotherapy of hepatocellular carcinoma]. , 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[34]  P. Roberson,et al.  Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  M. Burton,et al.  Dose distribution following selective internal radiation therapy. , 1991, International journal of radiation oncology, biology, physics.

[36]  P. Naredi,et al.  Aggregation of microspheres in blood flow measurements. , 1991, International journal of microcirculation, clinical and experimental.

[37]  R. Hultborn,et al.  Perfusion characteristics and norepinephrine reactivity of human renal carcinoma. , 1987, Cancer research.